AI‑driven protein design creates potent anti‑CRISPR inhibitors that block Cas13 activity, offering a new potential tool for safer, more controlled gene editing.

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Bacteria are present inside the most common type of kidney stone, revealing a previously unrecognized component involved in their formation.

WuXi Biologics says the company will provide the partnership with integrated, end-to-end biologics development and manufacturing services.

The Golden Gate Assembly platform engineers bacteriophages synthetically using sequence data rather than bacteriophage isolates.

Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.

Study found that that breath samples from children with asthma could predict intestinal abundance of a bacterium, Eubacterium siraeum, linked to the condition.

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

The discovery fundamentally changes the understanding of a structure in the avian eye that has been misinterpreted for centuries.

The so-called magneto-sensitive fluorescent proteins or MFPs, overcome key limitations of previous biological candidates for quantum sensors.

The new investment in the Holly Springs facility is on top of the initial commitment in May 2025, and groundbreaking in August 2025.